The two ABO variants rs579459 (chr9:133278724, C>T) and rs495828 (chr9:133279294, T>G) have been investigated and shown to influence immunological response, potentially impacting the severity of COVID-19 and ensuing cardiovascular problems [145]. This evidence concerns the gene ABO and COVID-19.